XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 177 $ 428,878 $ (357,794) $ 71,261
Balance (in shares) at Dec. 31, 2018 176,918,000      
Changes in Stockholders' Equity (Deficit)        
Issuance of common stock, net $ 26 26,731   26,757
Issuance of common stock (in shares) 26,136,000      
Exercise of stock options   93   93
Exercise of stock options (in shares) 230,000      
Stock-based compensation expense and vesting of RSUs   6,451   6,451
Stock-based compensation expense and vesting of RSUs (in shares) 82,000      
Issuance of warrants related to debt, net   723   723
Net loss     (79,938) (79,938)
Balance at Sep. 30, 2019 $ 203 462,876 (437,732) 25,347
Balance (in shares) at Sep. 30, 2019 203,366,000      
Balance at Jun. 30, 2019 $ 177 433,228 (418,233) 15,172
Balance (in shares) at Jun. 30, 2019 177,031,000      
Changes in Stockholders' Equity (Deficit)        
Issuance of common stock, net $ 26 26,731   26,757
Issuance of common stock (in shares) 26,136,000      
Exercise of stock options (in shares) 179,000      
Stock-based compensation expense and vesting of RSUs   2,194   2,194
Stock-based compensation expense and vesting of RSUs (in shares) 20,000      
Issuance of warrants related to debt, net   723   723
Net loss     (19,499) (19,499)
Balance at Sep. 30, 2019 $ 203 462,876 (437,732) 25,347
Balance (in shares) at Sep. 30, 2019 203,366,000      
Balance at Dec. 31, 2019 $ 203 464,491 (473,343) (8,649)
Balance (in shares) at Dec. 31, 2019 203,453,000      
Changes in Stockholders' Equity (Deficit)        
Issuance of common stock, net   (86)   $ (86)
Issuance of common stock (in shares) 175,000     175,289
Exercise of stock options and ESPP purchases $ 2 573   $ 575
Exercise of stock options and ESPP purchases (in shares) 2,220,000      
Exchange and conversion of convertible notes, net $ 39 20,082   20,121
Exchange and conversion of convertible notes, net (in shares) 38,391,000      
Stock-based compensation expense and vesting of RSUs   5,581   5,581
Issuance of warrants related to debt, net   1,212   1,212
Net loss     (73,536) (73,536)
Balance at Sep. 30, 2020 $ 244 491,853 (546,879) (54,782)
Balance (in shares) at Sep. 30, 2020 244,239,000      
Balance at Jun. 30, 2020 $ 231 483,615 (523,451) $ (39,605)
Balance (in shares) at Jun. 30, 2020 230,553,000      
Changes in Stockholders' Equity (Deficit)        
Issuance of common stock (in shares)       0
Exercise of stock options and ESPP purchases $ 1 76   $ 77
Exercise of stock options and ESPP purchases (in shares) 1,188,000      
Exchange and conversion of convertible notes, net $ 12 5,859   5,871
Exchange and conversion of convertible notes, net (in shares) 12,498,000      
Stock-based compensation expense and vesting of RSUs   2,303   2,303
Net loss     (23,428) (23,428)
Balance at Sep. 30, 2020 $ 244 $ 491,853 $ (546,879) $ (54,782)
Balance (in shares) at Sep. 30, 2020 244,239,000